Impact Factor
3.23
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.32
180 total citations
h5-index
15
h5 depth signal
Cited share
81.0%
51 of 63
Total citations
180
Citation footprint
Metric signal
2.81
External metric anchor
Self-citation
0.6%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Sweden
265
United States
14
United Kingdom
13
China
10
Denmark
9
Citing Fields of Research
Human Reproduction
47
Cardiology
35
Diabetes
29
Medical Ethics
27
Reproductive Health
25
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,786
Articles tracked across the journal lifetime
Indexed publication set
63
51 cited publications
Last 12 months
20
2.0 publications/month
Open access share
100.0%
20 OA publications in the last year
Leading citing country
Sweden
265 citing publications
Leading citing field
Human Reproduction
47 citing publications
Latest tracked publication
1 October 2026
10 recent records available
Coverage & Indexing History
v77n1, 1972-
v77n1, 1972-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Vascular Disorders
Musculoskeletal Disorders
Sexually Transmitted Diseases
Ophthalmology
Immunology
Auto-Inflammatory Disorders
Issuing & Sponsoring Bodies
Contributor
Upsala Medical Society
Broad Categories
Medicine
Cardiology
Urology
Virology
Lipids
Ophthalmology
Liver & Colon Cancer
Brain Imaging
MeSH Descriptors
Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.48101/ujms.v131.14276
Open DOI
De novo development of JAK2V617F-positive polycythemia vera following allogeneic hematopoietic stem cell transplantation: a report of two rare cases
Introduction: Post-transplant erythrocytosis following allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare and has been reported mainly in patients with aplastic anemia and, less frequently, after transplantation for o...
02
DOI 10.48101/ujms.v131.14047
Open DOI
Sex differences in monitoring and achievement of blood pressure and LDL-cholesterol targets in chronic coronary syndrome
Background: The cornerstones of secondary prevention in chronic coronary syndrome (CCS) are blood pressure lowering and lipid-lowering therapy (LLT). The purpose of this study was to examine the control of systolic blood pressure (SBP) a...
03
DOI 10.48101/ujms.v131.14245
Open DOI
Immune checkpoint inhibitor treatment – real-world use and outcomes in Sweden 2015–2023
Background: The introduction of immune checkpoint inhibitor (ICI) treatment has significantly improved the treatment of several cancer diagnoses, such as non-small cell lung cancer, renal and urothelial carcinoma, melanoma. However, ther...
04
DOI 10.48101/ujms.v131.14421
Open DOI
Multiple endocrine neoplasia type 1 with concurrent Cushing’s disease, prolactinoma, and multifocal pancreatic neuroendocrine tumors including insulinoma: a case report
Background: Multiple Endocrine Neoplasia type 1 (MEN1) is an autosomal dominant tumor predisposition syndrome involving primary hyperparathyroidism (PHPT), pituitary neuroendocrine tumors (PitNETs), and pancreatic neuroendocrine tumors. ...
05
DOI 10.48101/ujms.v131.14142
Open DOI
Altered placental expression of small humanin-like peptides in gestational diabetes mellitus
Background: Gestational diabetes mellitus (GDM) is characterized by maternal insulin resistance and hyperglycemia and has been associated with placental mitochondrial alterations. Small humanin-like peptides (SHLP1–6), encoded within the...
06
DOI 10.48101/ujms.v131.14458
Open DOI
Isolated atrial amyloidosis from atrial natriuretic peptide – a common but overlooked cardiac condition
Interest in the misfolding and aggregation of human proteins into amyloid fibrils has increased dramatically in recent years. The systemic amyloidoses constitute a group of serious disorders that often affect the heart. Each systemic amy...
07
DOI 10.48101/ujms.v131.13817
Open DOI
Positron Emission Tomography imaging of tumor necrosis factor in lung injury
Introduction: Tumor necrosis factor (TNF) is a key pro-inflammatory cytokine involved in various pulmonary diseases, including idiopathic pulmonary fibrosis (IPF), where it contributes to immune cell recruitment, tissue remodeling, and d...
08
DOI 10.48101/ujms.v131.13765
Open DOI
Disseminated Ureaplasma infection: a case report of a patient with rheumatoid arthritis on rituximab therapy with multiple abscesses and arthritis
A 51-year-old woman with rheumatoid arthritis treated with rituximab and leflunomide presented with a 5-month history of malodorous vaginal discharge. Initial examination revealed vulvovaginitis and cervicitis, and she was treated with m...
09
DOI 10.48101/ujms.v131.13678
Open DOI
Low-intensity pulsed ultrasound restores mitochondrial dynamics and function in lipopolysaccharide-stimulated astrocytes
Background: Low-intensity pulsed ultrasound (LIPUS) is a non-invasive therapeutic modality with growing potential in the treatment of neurodegenerative diseases. However, its mechanistic role in regulating mitochondrial homeostasis in as...
10
DOI 10.48101/ujms.v131.13337
Open DOI
Endocan attenuates LPS-induced alveolar type II cells injury through PI3K/Akt/mTOR pathway
Background: Alveolar type II (AT2) cell injury plays an important role in the pathogenesis of acute lung injury (ALI), but the corresponding treatment options are limited in clinical practice. Endocan has been proved to exert a protectiv...
Bibliographical & Catalog Notes
Place of publication varies.
Print issues ceased with V. 120 (2015).
Also issued online.
Vol. 85, no. 1 (1980)19921023 Notice not published Printed on acid-free paper